Scarica l'app Stockscreener
1.00
0.98%
0.01
Precedente Chiudi:
$1.01
Aprire:
$1.02
Volume 24 ore:
102.79K
Relative Volume:
0.05
Capitalizzazione di mercato:
$13.20M
Reddito:
-
Utile/perdita netta:
$-9.70M
Rapporto P/E:
-0.9091
EPS:
-1.1
Flusso di cassa netto:
$-8.57M
1 W Prestazione:
-5.56%
1M Prestazione:
+6.84%
6M Prestazione:
-0.98%
1 anno Prestazione:
-62.37%
Intervallo 1D:
$0.97
$1.02
Intervallo di 1 settimana:
$0.97
$1.13
Portata 52W:
$0.8099
$5.95
Marker Therapeutics Inc Stock (MRKR) Company Profile
Nome
Marker Therapeutics Inc
Settore
Industria
Telefono
(713) 400-6400
Indirizzo
2450 HOLCOMBE BLVD, HOUSTON, TX
Confronta MRKR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MRKR
Marker Therapeutics Inc
|
1.0199 | 13.07M | 0 | -9.70M | -8.57M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.17 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
459.49 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.93 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.01 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
329.04 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Marker Therapeutics Inc Stock (MRKR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-03-05 | Iniziato | Canaccord Genuity | Buy |
| 2021-03-25 | Iniziato | Piper Sandler | Overweight |
| 2021-03-19 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-05-12 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2019-05-30 | Iniziato | ROTH Capital | Buy |
| 2019-03-01 | Iniziato | Janney | Buy |
| 2018-12-03 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
Mostra tutto
Marker Therapeutics Inc Borsa (MRKR) Ultime notizie
Is this a good reentry point in Marker Therapeutics Inc.Weekly Market Outlook & Low Risk High Win Rate Stock Picks - newser.com
Does Marker Therapeutics Inc. show high probability of reboundTrade Risk Report & Free Expert Approved Momentum Trade Ideas - newser.com
Using R and stats models for Marker Therapeutics Inc. forecasting2025 Top Gainers & Stepwise Trade Signal Implementation - newser.com
Tools to assess Marker Therapeutics Inc.’s risk profileMarket Growth Summary & Free Weekly Chart Analysis and Trade Guides - newser.com
Developing predictive dashboards with Marker Therapeutics Inc. dataJuly 2025 Patterns & Free Community Consensus Stock Picks - newser.com
What valuation multiples suggest for Marker Therapeutics Inc. stockPortfolio Update Report & Advanced Swing Trade Entry Alerts - newser.com
Marker Therapeutics Inc. stock retracement – recovery analysisQuarterly Portfolio Report & Verified Momentum Watchlists - newser.com
Volatility clustering patterns for Marker Therapeutics Inc.Dip Buying & Fast Gain Stock Tips - newser.com
Why retail investors pile into Marker Therapeutics Inc. stock2025 Top Gainers & High Win Rate Trade Tips - newser.com
Marker Therapeutics Inc. stock daily chart insightsAnalyst Downgrade & Entry Point Confirmation Signals - newser.com
Real time breakdown of Marker Therapeutics Inc. stock performanceJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com
Best data tools to analyze Marker Therapeutics Inc. stock2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
What makes Marker Therapeutics Inc. (GX1) stock appealing to growth investorsJuly 2025 Levels & Technical Buy Zone Confirmations - newser.com
Marker Therapeutics Announces First Patient Treated in Off-the-Shelf Program - Sahm
Marker Therapeutics Advances Off-the-Shelf T Cell Therapy with First Patient Treatment - TipRanks
Marker Therapeutics Launches Phase 1 RAPID Trial for Multi-Antigen Recognizing T Cells as Off-the-Shelf Treatment for AML and MDS - Quiver Quantitative
100x10^6‑cell initial dose: Marker Therapeutics treats first patient with MT‑401 in Phase 1 OTS RAPID study - Stock Titan
Marker Therapeutics Inc GX1 Stock Analysis and ForecastSwing Trading Watchlist & Exceptional Capital Trading - earlytimes.in
Is Marker Therapeutics Inc. trending in predictive chart models2025 Investor Takeaways & Reliable Volume Spike Alerts - newser.com
Will Marker Therapeutics Inc. stock maintain momentum in 2025Quarterly Portfolio Summary & Daily Entry Point Alerts - newser.com
How forex fluctuations impact Marker Therapeutics Inc. (GX1) stockMarket Risk Report & AI Enhanced Execution Alerts - newser.com
Will Marker Therapeutics Inc. (GX1) stock split increase liquidity2025 Top Gainers & Smart Investment Allocation Tips - newser.com
Is Marker Therapeutics Inc. (GX1) stock worth holding before Fed meeting2025 Trading Volume Trends & Weekly High Conviction Trade Ideas - newser.com
Is Marker Therapeutics Inc. (GX1) stock prepared for digital transition2025 Short Interest & Real-Time Volume Trigger Notifications - newser.com
Visualizing Marker Therapeutics Inc. stock with heatmapsJuly 2025 Levels & Reliable Entry Point Alerts - newser.com
Marker Therapeutics Inc Azioni (MRKR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Marker Therapeutics Inc Azioni (MRKR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| New Enterprise Associates 16, | 10% Owner |
Dec 23 '24 |
Buy |
3.20 |
554,250 |
1,773,600 |
1,625,678 |
0.21%
2.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):